Business · 18/12/2008
FDA Announces Funding Opportunity for Rare Disease Clinical Studies
The FDA's Office of Orphan Product Development is seeking proposals for grants to support clinical studies on safety and effectiveness of orphan products for rare diseases, with the goal of securing market approval.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →